Chromosome Instability Underlies Hematopoietic Stem Cell Dysfunction and Lymphoid Neoplasia Associated with Impaired Fbw7-Mediated Cyclin E Regulation

REFERENCES

• Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L, Bockamp E, Lio P, Macdonald HR, Trumpp A. 2008. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135:1118–1129. http://dx.doi.org/10.1016/j.cell.2008.10.048.
   PubMed Web of Science ®Google Scholar
• Cheshier SH, Morrison SJ, Liao X, Weissman IL. 1999. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc. Natl. Acad. Sci. U. S. A. 96:3120–3125. http://dx.doi.org/10.1073/pnas.96.6.3120.
   PubMed Web of Science ®Google Scholar
• Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. 2005. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 202:1599–1611. http://dx.doi.org/10.1084/jem.20050967.
   PubMed Web of Science ®Google Scholar
• Coller HA. 2011. Cell biology. The essence of quiescence. Science 334:1074–1075. http://dx.doi.org/10.1126/science.1216242.
   PubMedGoogle Scholar
• Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:1804–1808. http://dx.doi.org/10.1126/science.287.5459.1804.
   PubMed Web of Science ®Google Scholar
• Cheng T, Rodrigues N, Dombkowski D, Stier S, Scadden DT. 2000. Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat. Med. 6:1235–1240. http://dx.doi.org/10.1038/81335.
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Takeishi S, Kanie T, Susaki E, Onoyama I, Tateishi Y, Nakayama K, Nakayama KI. 2011. p57 is required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell 9:262–271. http://dx.doi.org/10.1016/j.stem.2011.06.014.
   PubMed Web of Science ®Google Scholar
• Zou P, Yoshihara H, Hosokawa K, Tai I, Shinmyozu K, Tsukahara F, Maru Y, Nakayama K, Nakayama KI, Suda T. 2011. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell 9:247–261. http://dx.doi.org/10.1016/j.stem.2011.07.003.
   PubMed Web of Science ®Google Scholar
• Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, Butte AJ, Passegue E, Sage J. 2008. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell 3:416–428. http://dx.doi.org/10.1016/j.stem.2008.07.009.
   PubMed Web of Science ®Google Scholar
• Chen J, Ellison FM, Keyvanfar K, Omokaro SO, Desierto MJ, Eckhaus MA, Young NS. 2008. Enrichment of hematopoietic stem cells with SLAM and LSK markers for the detection of hematopoietic stem cell function in normal and Trp53 null mice. Exp. Hematol. 36:1236–1243. http://dx.doi.org/10.1016/j.exphem.2008.04.012.
   PubMedGoogle Scholar
• Liu Y, Elf SE, Miyata Y, Sashida G, Huang G, Di Giandomenico S, Lee JM, Deblasio A, Menendez S, Antipin J, Reva B, Koff A, Nimer SD. 2009. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4:37–48. http://dx.doi.org/10.1016/j.stem.2008.11.006.
   PubMed Web of Science ®Google Scholar
• Milyavsky M, Gan OI, Trottier M, Komosa M, Tabach O, Notta F, Lechman E, Hermans KG, Eppert K, Konovalova Z, Ornatsky O, Domany E, Meyn MS, Dick JE. 2010. A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 7:186–197. http://dx.doi.org/10.1016/j.stem.2010.05.016.
   PubMed Web of Science ®Google Scholar
• Santaguida M, Schepers K, King B, Sabnis AJ, Forsberg EC, Attema JL, Braun BS, Passegue E. 2009. JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Cancer Cell 15:341–352. http://dx.doi.org/10.1016/j.ccr.2009.02.016.
   PubMedGoogle Scholar
• Yu H, Yuan Y, Shen H, Cheng T. 2006. Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners. Blood 107:1200–1206. http://dx.doi.org/10.1182/blood-2005-02-0685.
   PubMedGoogle Scholar
• Yuan Y, Shen H, Franklin DS, Scadden DT, Cheng T. 2004. In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat. Cell Biol. 6:436–442. http://dx.doi.org/10.1038/ncb1126.
   PubMedGoogle Scholar
• Welcker M, Clurman BE. 2008. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 8:83–93. http://dx.doi.org/10.1038/nrc2290.
   PubMed Web of Science ®Google Scholar
• Thompson BJ, Jankovic V, Gao J, Buonamici S, Vest A, Lee JM, Zavadil J, Nimer SD, Aifantis I. 2008. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J. Exp. Med. 205:1395–1408. http://dx.doi.org/10.1084/jem.20080277.
   PubMedGoogle Scholar
• Matsuoka S, Oike Y, Onoyama I, Iwama A, Arai F, Takubo K, Mashimo Y, Oguro H, Nitta E, Ito K, Miyamoto K, Yoshiwara H, Hosokawa K, Nakamura Y, Gomei Y, Iwasaki H, Hayashi Y, Matsuzaki Y, Nakayama K, Ikeda Y, Hata A, Chiba S, Nakayama KI, Suda T. 2008. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL. Genes Dev. 22:986–991. http://dx.doi.org/10.1101/gad.1621808.
   PubMedGoogle Scholar
• Onoyama I, Tsunematsu R, Matsumoto A, Kimura T, de Alboran IM, Nakayama K, Nakayama KI. 2007. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J. Exp. Med. 204:2875–2888. http://dx.doi.org/10.1084/jem.20062299.
   PubMed Web of Science ®Google Scholar
• Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, Rideout WM, Bronson RT, Gardner H, Sicinski P. 2003. Cyclin E ablation in the mouse. Cell 114:431–443. http://dx.doi.org/10.1016/S0092-8674(03)00645-7.
   PubMed Web of Science ®Google Scholar
• Siu KT, Rosner MR, Minella AC. 2012. An integrated view of cyclin E function and regulation. Cell Cycle 11:57–64. http://dx.doi.org/10.4161/cc.11.1.18775.
   PubMed Web of Science ®Google Scholar
• Minella AC, Loeb KR, Knecht A, Welcker M, Varnum-Finney BJ, Bernstein ID, Roberts JM, Clurman BE. 2008. Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo. Genes Dev. 22:1677–1689. http://dx.doi.org/10.1101/gad.1650208.
   PubMedGoogle Scholar
• Koepp DM, Schaefer LK, Ye X, Keyomarsi K, Chu C, Harper JW, Elledge SJ. 2001. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294:173–177. http://dx.doi.org/10.1126/science.1065203.
   PubMed Web of Science ®Google Scholar
• Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI. 2001. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413:316–322. http://dx.doi.org/10.1038/35095076.
   PubMed Web of Science ®Google Scholar
• Xu Y, Swartz KL, Siu KT, Bhattacharyya M, Minella AC. 2014. Fbw7-dependent cyclin E regulation ensures terminal maturation of bone marrow erythroid cells by restraining oxidative metabolism. Oncogene 33:3161–3171. http://dx.doi.org/10.1038/onc.2013.289.
   PubMedGoogle Scholar
• Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM. 1996. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10:1979–1990. http://dx.doi.org/10.1101/gad.10.16.1979.
   PubMed Web of Science ®Google Scholar
• Minella AC, Welcker M, Clurman BE. 2005. Ras activity regulates cyclin E degradation by the Fbw7 pathway. Proc. Natl. Acad. Sci. U. S. A. 102:9649–9654. http://dx.doi.org/10.1073/pnas.0503677102.
   PubMedGoogle Scholar
• Xu D, Liu X, Yu WM, Meyerson HJ, Guo C, Gerson SL, Qu CK. 2011. Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells. J. Exp. Med. 208:1977–1988. http://dx.doi.org/10.1084/jem.20110450.
   PubMed Web of Science ®Google Scholar
• Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL. 2004. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Res. 64:8541–8549. http://dx.doi.org/10.1158/0008-5472.CAN-04-1992.
   PubMed Web of Science ®Google Scholar
• Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:1109–1121. http://dx.doi.org/10.1016/j.cell.2005.05.026.
   PubMed Web of Science ®Google Scholar
• Randall TD, Weissman IL. 1997. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 89:3596–3606.
   PubMed Web of Science ®Google Scholar
• Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE. 2002. p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation. Curr. Biol. 12:1817–1827. http://dx.doi.org/10.1016/S0960-9822(02)01225-3.
   PubMed Web of Science ®Google Scholar
• Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed SI. 2004. Deregulation of cyclin E in human cells interferes with prereplication complex assembly. J. Cell Biol. 165:789–800. http://dx.doi.org/10.1083/jcb.200404092.
   PubMed Web of Science ®Google Scholar
• Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B, Lengauer C. 2004. Inactivation of hCDC4 can cause chromosomal instability. Nature 428:77–81. http://dx.doi.org/10.1038/nature02313.
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512. http://dx.doi.org/10.1101/gad.13.12.1501.
   PubMed Web of Science ®Google Scholar
• Minella AC, Grim JE, Welcker M, Clurman BE. 2007. p53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability. Oncogene 26:6948–6953. http://dx.doi.org/10.1038/sj.onc.1210518.
   PubMedGoogle Scholar
• Gupta M, Gupta SK, Balliet AG, Hollander MC, Fornace AJ, Hoffman B, Liebermann DA. 2005. Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis. Oncogene 24:7170–7179. http://dx.doi.org/10.1038/sj.onc.1208847.
   PubMed Web of Science ®Google Scholar
• Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace AJJr. 1999. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23:176–184. http://dx.doi.org/10.1038/13802.
   PubMed Web of Science ®Google Scholar
• Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA, Fukasawa K. 2000. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene 19:1635–1646. http://dx.doi.org/10.1038/sj.onc.1203460.
   PubMed Web of Science ®Google Scholar
• Thompson SL, Bakhoum SF, Compton DA. 2010. Mechanisms of chromosomal instability. Curr. Biol. 20:R285–R295. http://dx.doi.org/10.1016/j.cub.2010.01.034.
   PubMed Web of Science ®Google Scholar
• Orford KW, Scadden DT. 2008. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation. Nat. Rev. Genetics 9:115–128. http://dx.doi.org/10.1038/nrg2269.
   PubMed Web of Science ®Google Scholar
• Kimura T, Gotoh M, Nakamura Y, Arakawa H. 2003. hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53. Cancer Sci. 94:431–436. http://dx.doi.org/10.1111/j.1349-7006.2003.tb01460.x.
   PubMed Web of Science ®Google Scholar
• Mao JH, Perez-Losada J, Wu D, Delrosario R, Tsunematsu R, Nakayama KI, Brown K, Bryson S, Balmain A. 2004. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 432:775–779. http://dx.doi.org/10.1038/nature03155.
   PubMed Web of Science ®Google Scholar
• Xu Y, Sengupta T, Kukreja L, Minella AC. 2010. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7. J. Biol. Chem. 285:34439–34446. http://dx.doi.org/10.1074/jbc.M110.152306.
   PubMedGoogle Scholar
• Mavrakis KJ, Van Der Meulen J, Wolfe AL, Liu X, Mets E, Taghon T, Khan AA, Setty M, Rondou P, Vandenberghe P, Delabesse E, Benoit Y, Socci NB, Leslie CS, Van Vlierberghe P, Speleman F, Wendel HG. 2011. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat. Genet. 43:673–678. http://dx.doi.org/10.1038/ng.858.
   PubMed Web of Science ®Google Scholar
• Balamurugan K, Wang JM, Tsai HH, Sharan S, Anver M, Leighty R, Sterneck E. 2010. The tumour suppressor C/EBPdelta inhibits FBXW7 expression and promotes mammary tumour metastasis. EMBO J. 29:4106–4117. http://dx.doi.org/10.1038/emboj.2010.280.
   PubMed Web of Science ®Google Scholar
• Figueroa ME, Skrabanek L, Li Y, Jiemjit A, Fandy TE, Paietta E, Fernandez H, Tallman MS, Greally JM, Carraway H, Licht JD, Gore SD, Melnick A. 2009. MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood 114:3448–3458. http://dx.doi.org/10.1182/blood-2009-01-200519.
   PubMed Web of Science ®Google Scholar
• Geng Y, Lee YM, Welcker M, Swanger J, Zagozdzon A, Winer JD, Roberts JM, Kaldis P, Clurman BE, Sicinski P. 2007. Kinase-independent function of cyclin E. Mol. Cell 25:127–139. http://dx.doi.org/10.1016/j.molcel.2006.11.029.
   PubMed Web of Science ®Google Scholar
• Grim JE, Knoblaugh SE, Guthrie KA, Hagar A, Swanger J, Hespelt J, Delrow JJ, Small T, Grady WM, Nakayama KI, Clurman BE. 2012. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer. Mol. Cell. Biol. 32:2160–2167. http://dx.doi.org/10.1128/MCB.00305-12.
   PubMedGoogle Scholar
• Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, Takaoka M, Nakagawa H, Tort F, Fugger K, Johansson F, Sehested M, Andersen CL, Dyrskjot L, Orntoft T, Lukas J, Kittas C, Helleday T, Halazonetis TD, Bartek J, Gorgoulis VG. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633–637. http://dx.doi.org/10.1038/nature05268.
   PubMed Web of Science ®Google Scholar
• Fragkos M, Beard P. 2011. Mitotic catastrophe occurs in the absence of apoptosis in p53-null cells with a defective G1 checkpoint. PLoS One 6:e22946. http://dx.doi.org/10.1371/journal.pone.0022946.
   PubMed Web of Science ®Google Scholar
• Kenyon J, Fu P, Lingas K, Thomas E, Saurastri A, Santos Guasch G, Wald D, Gerson SL. 2012. Humans accumulate microsatellite instability with acquired loss of MLH1 protein in hematopoietic stem and progenitor cells as a function of age. Blood 120:3229–3236. http://dx.doi.org/10.1182/blood-2011-12-401950.
   PubMedGoogle Scholar
• Allsopp RC, Morin GB, DePinho R, Harley CB, Weissman IL. 2003. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102:517–520. http://dx.doi.org/10.1182/blood-2002-07-2334.
   PubMedGoogle Scholar